These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9211631)

  • 41. Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets.
    Woo KT; Wei SS; Lee EJ; Lau YK; Lim CH
    Nephron; 1985; 40(1):25-8. PubMed ID: 4000334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arterial hypoxemia during hemodialysis for acute renal failure in mechanically ventilated patients: observations and mechanisms.
    Jones RH; Broadfield JB; Parsons V
    Clin Nephrol; 1980 Jul; 14(1):18-22. PubMed ID: 6773711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of hemodialysis induced hypoxemia and leukopenia in Chinese uremics].
    Chen CF; Shieh SD; Fan CD; Huang HW; Lee WC; Kao KS
    Taiwan Yi Xue Hui Za Zhi; 1983 Jan; 82(1):107-112. PubMed ID: 6575116
    [No Abstract]   [Full Text] [Related]  

  • 44. Picotamide, selective inhibitor of thromboxane synthesis in patients on maintenance hemodialysis.
    Vandelli L; Grosoli M; Lusvarghi E; Cenci AM; Campioli D; Grossi G
    Nephrol Dial Transplant; 1989; 4(12):1083-4. PubMed ID: 2517331
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of vitamin E on platelet function and anemia in patients on long-term hemodialysis].
    Janicka L; Dmoszyńska A; Ksiazek A; Kozioł M
    Pol Tyg Lek; 1988 Nov; 43(48):1557-8. PubMed ID: 3255907
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment.
    Bemis J; Rigney J; Sosin A; Deane N
    Trans Am Soc Artif Intern Organs; 1977; 23():48-53. PubMed ID: 910370
    [No Abstract]   [Full Text] [Related]  

  • 47. Increased reticulated platelets in dialysis patients.
    Himmelfarb J; Holbrook D; McMonagle E; Ault K
    Kidney Int; 1997 Mar; 51(3):834-9. PubMed ID: 9067918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leucopenia and hypoxemia during hemodialysis with different membranes: effect of prostacyclin.
    De Broe ME; De Backer WA; Verpooten GA; Vermeire PA; Van Waeleghem JP; Herman AG
    Contrib Nephrol; 1983; 36():26-30. PubMed ID: 6340951
    [No Abstract]   [Full Text] [Related]  

  • 49. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis.
    Luzzatto G; Bertoli M; Cella G; Fabris F; Zaia B; Girolami A
    Thromb Res; 1998 Feb; 89(3):115-22. PubMed ID: 9622039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of erythropoietin on platelet function and fibrinolysis in chronic renal failure.
    Stenver D; Jeppesen L; Nielsen B; Dalsgaard Nielsen J; Haedersdal C; Mehlsen J; Winther K
    Int J Artif Organs; 1994 Mar; 17(3):141-5. PubMed ID: 8050804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of recombinant human erythropoietin on thrombocyte aggregation capacity and on the blood prostanoid level in patients with chronic kidney failure on hemodialysis].
    Rud'ko IA; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
    Ter Arkh; 1991; 63(10):128-30. PubMed ID: 1805410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The beginning of repeated hemodialysis treatment enhances some platelet functions in uremic patients.
    Krawczyk W; Dmoszýnska A; Marczewski K
    Nephron; 1995; 71(3):361-2. PubMed ID: 8569990
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of the biocompatibility of dialyzers by leukocyte kinetics and the dynamics of the blood acid-base balance].
    Iarmolinskiĭ IS; STetsiuk EA; Efimov NN; Sidorenko AM
    Urol Nefrol (Mosk); 1987; (5):43-6. PubMed ID: 3424468
    [No Abstract]   [Full Text] [Related]  

  • 56. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
    Aggarwal A; Kabbani SS; Rimmer JM; Gennari FJ; Taatjes DJ; Sobel BE; Schneider DJ
    Am J Kidney Dis; 2002 Aug; 40(2):315-22. PubMed ID: 12148104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients.
    da Silva CD; Brunini TM; Reis PF; Moss MB; Santos SF; Roberts NB; Ellory JC; Mann GE; Mendes-Ribeiro AC
    Kidney Int; 2005 Nov; 68(5):2173-9. PubMed ID: 16221216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the effects of cellulose triacetate and polysulfone membrane on GPIIb/IIIa and platelet activation.
    Kuragano T; Kuno T; Takahashi Y; Yamamoto C; Nagura Y; Takahashi S; Kanmatsuse K
    Blood Purif; 2003; 21(2):176-82. PubMed ID: 12601261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes.
    Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M
    Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.